Efectos de la rehabilitación pulmonar de corta duración en pacientes con EPOC

  1. E. Paz Fernández 1
  2. A. López García 2
  3. L. González Doniz 2
  4. S. Souto Camba 2
  5. R. Fernández Cervantes 2
  1. 1 Centro de Fisioterapia Fisiomare, La Coruña
  2. 2 Universidade da Coruña
    info

    Universidade da Coruña

    La Coruña, España

    ROR https://ror.org/01qckj285

Journal:
Fisioterapia

ISSN: 0211-5638

Year of publication: 2015

Volume: 37

Issue: 5

Pages: 246-256

Type: Article

DOI: 10.1016/J.FT.2014.10.003 SCOPUS: 2-s2.0-84939570557 DIALNET GOOGLE SCHOLAR

More publications in: Fisioterapia

Abstract

Objective To determine the effects on exercise tolerance, dyspnea, and quality of life in short pulmonary rehabilitation programs in patients with COPD. Search strategies We searched in Pubmed, PEDro and Cochrane studies of supervised programs of short pulmonary rehabilitation, with intervention in respiratory muscles and lower limbs. Study selection A total of 13 studies, with programs from 10 to 18 sessions are considered, in an intervention period of 3-9 weeks. Synthesis results A total of 9 of 13 studies that measured exercise tolerance showed clinically meaningful outcomes. All studies assessing dyspnea had improved the final values. Two studies showed clinical significance in all quality of life domains, 5 in the total score of the questionnaire and 5 in symptoms domain. Conclusions The short-term pulmonary rehabilitation programs less than 16 sessions shows positive effects on exercise tolerance, dyspnea and quality of life, with a minimum components of muscular training upper and lower limbs and education.

Bibliographic References

  • Guía práctica clínica para el diagnóstico y tratamiento de pacientes con enfermedad pulmonar obstructiva crónica (EPOC)-Guías Española de la EPOC (GesEPOC). Arch Bronconeumol. 2012, 48:2-58. Grupo de trabajo de GesEPOC.
  • Llauger M.A., Pou M.A., Dominguez L., Freixas M., Valverde P., Valero C. Atención a la EPOC en el abordaje al paciente crónico en atención primaria. Arch Bronconeumol. 2011, 47:561-570.
  • Seoane B., Mena A., de la Iglesia F. La enfermedad pulmonar obstructiva crónica y el internista - 1a parte: una enfermedad sistémica. Galicia Clín. 2009, 70:25-28.
  • Casanova C., de Torres J.P., Montes de Oca M. Aspectos sistémicos y factores pronósticos. Arch Bronconeumol. 2007, 3:25-34.
  • Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176:532-555.
  • Guell M.R., Cejudo P., Rodriguez-Trigo G., Galdiz J.B., Casolive V., Regueiro M., et al. Standards for quality care in respiratory rehabilitation in patients with chronic pulmonary disease. Quality Healthcare Committee. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2012, 48:396-404.
  • Wehrmeister F.C., Knorst M., Jardim J.R., Macedo E.C., Noal R.B., Martinez-Mesa J., et al. Pulmonary rehabilitation programs for patients with COPD. J Bras Pneumol. 2011, 37:544-555.
  • Lacasse Y., Martin S., Lasserson T.J., Goldstein R.S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Eura Medicophys. 2007, 43:475-485.
  • De Lucas M.P., Güell R., Sobradillo V., Jiménez C., Sangenis M., Montemayor T., et al. Rehabilitación respiratoria. Arch Bronconeumol. 2000, 36:34-43.
  • Bustamamente L., Sívori M., Lavagnino D., Martínez A., Sáenz C. Discriminación de la limitación al ejercicio en pacientes con EPOC severa en pruebas máximas y submáximas. Rev Am Med Resp. 2011, 1:18-23.
  • Montes de Oca M., Ortega M., Lezama J., Lopez J.M. [Chronic obstructive pulmonary disease: Evaluation of exercise tolerance using three different exercise tests] [español]. Arch Bronconeumol. 2001, 37:69-74.
  • Puhan M.A., Mador M.J., Held U., Goldstein R., Guyatt G.H., Schunemann H.J. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008, 32:637-643.
  • Brouillard C., Pepin V., Milot J., Lacasse Y., Maltais F. Endurance shuttle walking test: Responsiveness to salmeterol in COPD. Eur Respir J. 2008, 31:579-584.
  • Singh S.J., Jones P.W., Evans R., Morgan M.D. Minimum clinically important improvement for the incremental shuttle walking test. Thorax. 2008, 63:775-777.
  • Pepin V., Laviolette L., Brouillard C., Sewell L., Singh S.J., Revill S.M., et al. Significance of changes in endurance shuttle walking performance. Thorax. 2011, 66:115-120.
  • Pruebas de ejercicio cardiopulmonar. Arch Bronconeumol. 2001, 37:247-268. Grupo de Trabajo de la SEPAR.
  • Casanova C., García-Talavera I., de Torres J.P. La disnea en la EPOC. Arch Bronconeumol. 2005, 41:24-32.
  • Borg G. Simple rating methods for estimation of perceived exertion. Physical work and effort 1977, Pergamon Press, Oxford. G. Borg (Ed.).
  • Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54:581-586.
  • Group W.H.O.Q.O.L. Study protocol for the World Health Organization Project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res. 1993, 2:153-159.
  • Rutten-van M., Roos B., van Noord J.A. An empirical comparison of the St George's respiratory questionnaire (SGRQ) and the Chronic respiratory disease questionnaire (CRQ) in a clinical trial setting. Thorax. 1999, 54:995-1003.
  • Hajiro T., Nishimura K. Minimal clinically significant difference in health status: The thorny path of health status measures?. Eur Respir J. 2002, 19:390-391.
  • Williams J.E., Singh S.J., Sewell L., Morgan M.D. Health status measurement: Sensitivity of the self-reported Chronic respiratory questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax. 2003, 58:515-518.
  • Schunemann H.J., Akl E.A., Guyatt G.H. Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective. Health Qual Life Outcomes. 2006, 4:62.
  • Swigris J.J., Brown K.K., Behr J., du Bois R.M., King T.E., Raghu G., et al. The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF. Respir Med. 2010, 104:296-304.
  • Vilagut G., Ferrer M., Rajmil L., Rebollo P., Permanyer-Miralda G., Quintana J.M., et al. El Cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit. 2005, 19:135-150.
  • Clini E., Foglio K., Bianchi L., Porta R., Vitacca M., Ambrosino N. In-hospital short-term training program for patients with chronic airway obstruction. Chest. 2001, 120:1500-1505.
  • Hui K.P., Hewitt A.B. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest. 2003, 124:94-97.
  • Norweg A.M., Whiteson J., Malgady R., Mola A., Rey M. The effectiveness of different combinations of pulmonary rehabilitation program components: A randomized controlled trial. Chest. 2005, 128:663-672.
  • Montes de Oca M., Torres S.H., Gonzalez Y., Romero E., Hernandez N., Talamo C. [Changes in exercise tolerance, health related quality of life, and peripheral muscle characteristics of chronic obstructive pulmonary disease patients after 6 weeks' training] [español]. Arch Bronconeumol. 2005, 41:413-418.
  • Rossi G., Florini F., Romagnoli M., Bellantone T., Lucic S., Lugli D., et al. Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest. 2005, 127:105-109.
  • Arnardottir R.H., Sorensen S., Ringqvist I., Larsson K. Two different training programmes for patients with COPD: A randomised study with 1-year follow-up. Respir Med. 2006, 100:130-139.
  • Sewell L., Singh S.J., Williams J.E., Collier R., Morgan M.D. How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax. 2006, 61:767-771.
  • Regiane Resqueti V., Gorostiza A., Galdiz J.B., Lopez E., Casan P., Guell R. [Benefits of a home-based pulmonary rehabilitation program for patients with severe chronic obstructive pulmonary disease] [español]. Arch Bronconeumol. 2007, 43:599-604.
  • Von Leupoldt A., Hahn E., Taube K., Schubert-Heukeshoven S., Magnussen H., Dahme B. Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity: Dyspnea, and quality of life in COPD. Lung. 2008, 186:387-391.
  • Du Moulin M., Taube K., Wegscheider K., Behnke M., van den Bussche H. Home-based exercise training as maintenance after outpatient pulmonary rehabilitation. Respiration. 2009, 77:139-145.
  • Riario-Sforza G.G., Incorvaia C., Paterniti F., Pessina L., Caligiuri R., Pravettoni C., et al. Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study. Int J Chron Obstruct Pulmon Dis. 2009, 4:315-319.
  • Linneberg A., Rasmussen M., Buch T.F., Wester A., Malm L., Fannikke G., et al. A randomised study of the effects of supplemental exercise sessions after a 7-week chronic obstructive pulmonary disease rehabilitation program. Clin Respir J. 2012, 6:112-119.
  • Egan C., Deering B.M., Blake C., Fullen B.M., McCormack N.M., Spruit M.A., et al. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012, 106:1671-1679.
Data source: Dialnet